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Epstein-Barr virus (EBV) is one of human herpesviruses and a member of the gamma 
herpesvirus family (lymphocryptovirus).  Infectious mononucleosis, Burkitt’s lymphoma 
and nasopharyngeal carcinoma are well-known EBV-associated diseases.  The range of 
EBV-associated diseases has recently expanded to include Hodgkin’s lymphoma, T-cell 
lymphoma, pyothorax-associated or methotrexate-associated B-cell lymphoma, primary 
effusion lymphoma and lymphoepithelioma-like carcinoma of the stomach, thymus and 
salivary gland, lymphoproliferative disorders (LPDs) or leiomyosarcomas from im-
munocompromized host, oral hairy leukoplakia, and EBV-associated hemophagocytic 
syndrome.  Animal models of human EBV-associated diseases are essential to elucidate 
the pathogenesis of EBV-infection and EBV-associated diseases.  However, only several 
reports on the animal models of EBV infection have been reported.  Here I review the 
summary of EBV-associated diseases in humans and those previous animal models using 
EBV or EBV-like herpesviruses and describe some details on our two newly developed 
rabbit models of LPD induced by simian EBV-like viruses and a mouse model with mu-
rine gammaherpesvirus.  These animal models are useful and inexpensive alternative 
experimental model systems for studying the biology and pathogenesis of EBV, and pro-
phylactic and therapeutic regimens. 
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Animal models for EBV infection 
and EBV-associated diseases
  
EBV-associated diseases and their animal models 
are tabulated in Table 2.  In this review, I will focus 
only on in vivo animal models for EBV-related dis-
eases.   
  
Animal models using human EBV
Monkey models using human EBV
        The host range of EBV is limited to humans 
and some new world monkeys (the cotton-top 
tamarin (Sanguinus oedipus oedipus), the common 
marmoset (Callithrix jacchus) and the owl monkey 
(Aotus trivirgatus).  The cotton-top tamarin pro-
vides an in vivo model for EBV-persistent infection 
and EBV-related lymphomagenesis (Niedobitek et 
al., 1994).  The EBV-infected cotton-top tamarins 
show a spectrum of responses that varies from 
unapparent infection to frank malignant lym-
phoma (Miller et al., 1977; Rickinson and Kieff, 
1996).  The cotton-top tamarin with inoculation of 
a high transforming dose of EBV developed mul-
tiple tumor foci composed of immunoblasts and 
plasmacytoid cells with the full spectrum of virus 
latent genes characteristic of latency type III infec-
tion (Cleary et al., 1985).  These experimentally 
induced lymphomas are very good for the B-cell 
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LPD seen in immunocompromised humans.  The 
common marmoset also provides an in vivo model 
for primary and persistent EBV infection, but not 
for EBV-related lymphoma.  However, the value 
of tamarin and marmoset model as a more general 
model for EBV infections in humans is limited by 
the inability to infect these animals via the natural 
oropharyngeal route and/or virus persistence in 
animals, which do not develop lymphoma (Rick-
inson and Kieff, 1996).  New World primates are 
endangered species, rare and so expensive that they 
are difficult to use for experiment.
SCID mouse model using human EBV
        Severe combined immunodeficiency disease 
(SCID) mice with xenografts of human EBV-in-
fected lymphocytes frequently developed oligoclo-
nal or polyclonal multiple foci of EBV-positive hu-
man B-cell LPD (Moiser et al., 1998).  These SCID 
tumor cells had a normal karyotype and showed 
latency type III infection with a small minority of 
cells expressing lytic viral proteins.  Analysis of 
EBV clonality revealed that these tumors contained 
multiple viral episomes and linear DNA indicating 
viral replication.  The SCID mouse model therefore 
is a convenient in vivo system in which to assess 
novel therapeutic regimes directed against EBV-
associated B cell LPD (Johannessen and Crawford, 
1999).
The other models using human EBV
        Some of rabbits orally inoculated with EBV 
(B95-8) showed EBV infection with continuous 
detection of EBV-DNA from peripheral blood by 
PCR for 18 weeks and transient rise of antibodies 
to EBV but developed no tumors (Koirala et al., 
1997; Chen et al., 1997).
        Studies of tumorigenic mechanisms have been 
promoted by the application of transgenic mouse 
technology (Wilson., 1997).  Candidate oncogenes 
can be definitively tested and their role in tumor 
formation dissected in vivo.  In developing trans-
genic mouse models of EBV-associated diseases, 
the mechanism of action of the viral proteins, 
gleaned from molecular and biochemical analyses, 
can be visualized as phenotypic consequence in the 
whole organism.  For examples, expression of the 
EBNA-1 or LMP-1 induces B cell lymphoma in 
transgenic mice (Wilson et al., 1996; Kulwichit et 
al., 1998). 
Animal models using EBV-like herpesvirus 
(lymphocryptovirus)
Simian models using naturally infected proper 
herpesvirus (Rhesus and Cynomolgus models)
        Lymphocryptoviruses (LCVs) are endemic in 
primate species and resemble each other in genom-
ic structure and gene organization.  Their structural 
and nonstructural proteins are frequently antigeni-
cally reactive across species (Kieff and Rickin-
son, 2001).  Not only various Old World monkey 
species but New World monkeys carry their own 
EBV-related LCV (Dillneer et al., 1987; Kieff and 
Rickinson, 2001; Wang et al., 2001).  And this is 
probably the reason why they were refractory to 
human EBV infection trials.  These viruses show 
extensive colinear genome homology with EBV, 
encode many antigenically related proteins includ-
ing EBNA-1 and EBNA-2 homologues, and can 
immortalize their natural target B cells in vitro but 
are not usually associated with any known disease 
of natural host monkeys.  Their common evolution-
ary origin with EBV strongly suggests that the es-
sential features of the virus-host interaction have 
been conserved (Rickinson and Kieff, 1996).
        Rhesus monkey provides a new model for 
primary and persistent EBV infection.  Experimen-
Abbreviations:  AIDS, acquired imunodeficiency syndrome; CTL, cytotoxic T lymphocyte; EBER, EBV-encoded 
small RNA; EBNA, EBV-determined nuclear antigen; EBV, Epstein-Barr virus; EBV-AHS, EBV-associated hemo-
phagocytic syndrome; HHV, human herpesvirus; HPS, hemophagocytic syndrome; HTLV, human T lymphotropic 
virus; HVMA, Herpesvirus Macaca arctoides; HVMF1, Herpesvirus Macaca fascicularis-1; HVMNE, Herpesvirus 
Macaca nemestrina; HVP, Herpesvirus papio; IM, infectious mononucleosis; LCV, lymphocryptvirus; LMP, latent 
membrane protein; LPD, lymphoproliferative disease; MHV, murine gammaherpesvirus; SCID, severe combined 
immunodeficiency; SIV, simian immunodeficiency virus; VAHS, virus-associated hemophagocytic syndrome; VCA, 
viral capsid antigen
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Table 2.  Animal models of EBV-associated diseases
Animal  models Viruses Diseases and pathology Similar EBV-associated    
 Animals used   diseases of humans
Animal models using human EBV
Monkey models
 Cotton-top  EBV EBV-associated LPD PTLD-like lymphoma (B-LPD)
    marmoset
 Calithrix  EBV EBV-associated LPD, mild PTLD-like lymphoma (B-LPD)
    marmoset
 Owl monkey EBV EBV-associated LPD,  PTLD-like lymphoma (B-LPD)
      disseminated
Mouse model
 SCID mouse EBV-infected lymphocyte Transplanted human LPD PTLD-like lymphoma (B-LPD)
The other animal models
 Hamster EBV-infected  lymphocyte Transplanted human LPD PTLD-like lymphoma (B-LPD)
     (newborn)
 Rabbit EBV Acute infection (mild IM) Mild IM
Animal models using EBV-like herpesvirus (lymphocryptovirus)
Monkey models using naturally infected proper herpesvirus
 Rhesus monkey Rhesus-EBV (lympho- Acute Rhesus-EBV infection  Acute EBV infection or IM; 
     cryptovirus) or IM; oral hairy leukoplakia oral hairy leukoplakia 
 Cynomolgus  Cynomolgus-EBV  Cynomolgus-EBV- PTLD-like lymphoma (B-LPD)
    with SIV     (herpesvirus from     associated LPD
    infection    Macaca fascicularis)
Mouse models using MHV
 Mouse (Balb/C) MHV-68 LPD PTLD-like lymphoma (B-LPD)
  Mouse (Balb/C) MHV-72 LPD PTLD-like lymphoma (B-LPD)
  Mouse (Balb/C) MHV-76 Acute infection Acute EBV infection or IM
Rabbit models using simian EBV-like herpesvirus
 Rabbit Cyno-EBV, Si-IIA- Cyno-EBV-associated   EBV-associated ML
     EBV (HVMF1)    ML (T-cell)     (T-cell)
 Rabbit Herpesvirus from Macaca  HVMA-associated ML EBV-associated ML (?)
     arctoides (HVMA) 
 Rabbit Herpesvirus from Macaca  HVMNE-associated  EBV-associated ML
    nemestrina  (HVMNE)    ML (T-cell)    (T-cell)
 Rabbit Boboon-EBV [Herpes- HVP-associatd fatal LPD   EBV-associated fatal LPD 
     virus papio (HVP)]    with VAHS (T-cell)    with VAHS (T-LPD)
B-LPD, B-cell LPD; LPD, lymphoproliferative disease; PTLD, post-transplant LPD; T-LPD, T-cell LPD; VAHS, 
virus-associated hemophagocytic syndrome.
tal oral inoculation of rhesus LCV in LCV-naïve 
rhesus monkeys resulted in acute and persistent 
LCV infection mimicking EBV infection in hu-
mans.  Acute responses resemble to those seen in 
humans infectious mononucleosis with atypical 
lymphocytosis and activated CD23-positive B cells 
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in peripheral blood with cross-reacting antibodies 
to EBNA2 and EBV-VCA.  Acute infection was 
followed by a persistent infection with shedding 
virus in saliva and harboring asymptomatic LCV 
in the peripheral blood.  However, without overt 
immunosuppression, LCV-related tumors have not 
developed in this model (Wang, 2001; Wang et al., 
2001).  Rhesus LCV can infect epithelial cells in 
immunosuppressed rhesus macaques and can in-
duce epithelial cell lesions resembling oral hairy 
leukoplakia in AIDS patients.  Electron microsco-
py, immunohistochemistry and DNA-RNA in situ 
hybridization were used to identify the presence of 
a lytic rhesus LCV infection in these proliferative, 
hyperkeratotic or parakeratotic epithelial cell le-
sions (Kutok et al., 2004).
        An EBV-like herpesvirus (Herpesvirus 
Macaca fascicularis -1, HVMF1) isolated from 
lymphomas of simian immunodeficiency virus 
(SIV)-infected Cynomolgus monkeys (Macaca fas-
cicularis) has been identified as a causative agent 
for a monkey model of EBV-associated lymphoma-
genesis in human AIDS (Feichtinger et al., 1992; 
Rezikyan et al., 1995).  Rhesus monkeys (Macaca 
mulatta) and Cynomolgus monkeys infected with 
a SIV developed B cell lymphomagenesis at 4% 
and 31% incidence, respectively, associated with an 
EBV-related simian herpesvirus (Rhesus LCV and 
HVMF1, respectively), providing a monkey model 
for EBV-associated lymphomagenesis at 3 to 6% 
incidence in human AIDS (Habis et al., 1999).  Of 
160 consecutive renal transplants of cynomolgus, 
5.6% developed B-cell LPD with EBER expression 
28 to 103 days after transplantation (Schmidtko et 
al., 2002). 
Mouse models using murine gamma-herpesvirus
        Murine herpesvirus 68 (MHV-68), a murine 
gammaherpesvirus, was isolated from a murid ro-
dent, the bank vole in Slovakia (Blaskovic et al., 
1980).  Seven more isolates similar to MHV-68 
(MHV-60, MHV-72, MHV-76, MHV-78, MHV-
Sumava, MHV- 4556 and MHV-5682) were 
also obtained.  At least three isolates, MHV-68, 
MHV-72 and MHV-Sumava seem to be involved 
in malignant neoplasm development in mice (Mis-
trikova et al., 2000).  Especially MHV-68 has been 
intensively investigated to be used as a mouse mod-
el for LPD induced by EBV.  Intranasal inoculation 
of MHV-68 in Balb/c mice induced viral infection 
and replication in the lung alveolar epithelia and 
mononuclear cells and subsequently followed by in-
fectious mononucleosis and/or persistent infection 
in murine B cells.  Twenty of 220 (9%) persistently 
infected mice developed MHV-68-associated LPD 
during 3 years observation and the LPD incidence 
of MHV-68 infected mice with Cyclosporin A 
treatment increased to 60% (Sunil-Chandra et al., 
1994).  In situ hybridization revealed the presence 
of viral DNA and the expression of viral RNA in 
the lymphoid cells of LPD lesions.  An MHV-68-
infected B cell line derived from an LPD lesion 
showed tumorigenicity in nude mice (Usherwood 
et al., 1996).  Atypical lymphocytosis in acute 
phase of mouse MHV-72 infection, like infectious 
mononucleosis in humans and LPD development 
in MHV-72-infected Balb/c mice, were reported 
(Mistrikova and Mrmusova, 1998).  Pathology of 
MHV-72-infection in CB17 +/+ and CB17 scid/scid 
mice was examined (Fig. 2; Oda et al., submitted). 
Comparative genomic sequence analysis of MHV 
variants and their different pathogenesis were 
shown in Table 3 (Macrae et al., 2001; Oda et al., 
submitted). Many aspects of MHV-68 or MHV-72 
infection in mice are similar to those of human 
EBV infection and this is a useful model for the 
study of gammmaherpesvirus infection in vivo.
Rabbit models using simian EBV-like herpesviruses
         Rabbit T-cell lymphoma model induced by 
Cynomolgus-EBV (herpesvirus from Macaca 
fascularis):  I previously established a simian (Cy-
nomolgus monkey) leukocyte cell line (Si-IIA) by 
cocultivation with an human T lymphotropic virus 
(HTLV)-II-producing human CD8+ T cell line 
(HTLV-IIA) (Miyamoto et al., 1990).  Si-IIA cells 
immortalize human T cells (Hayashi et al., 1993; 
Ohara et al., 1993).  During a study on the preven-
tion of HTLV-II infection using Si-IIA, I found 
by chance that malignant lymphoma develops in 
Japanese White rabbits when they were inoculated 
intravenously and that these rabbit lymphomas had 
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Fig. 2.  Pathology of MHV-72-infected mice.
 a: Acute bronchopneumonia induced by nasal inoculation of MHV-72 in CB17 +/+ mouse. 
 b: Malignant lymphoma occurred in the spleen of MHV-72-infected CB17 +/+ mouse.  
 c: Hemophagocytosis detected in the spleen of MHV-72-infected CB17+/+ mouse.  
 d & e: Intranuclear inclusions of herpesvirus in the many hepatocytes of MHV-72-infected CB17 scid/scid mouse. 
 f: Detection of MHV-DNA in MHV-72-infected mouse tissues by PCR using MHV-68 primers. 
v-cyclin gene was detected in MHV-72-infected mouse tissues (lanes 1 through 7), MHV-68 (lane P68) and 
MHV-72 (lane P72).  However, M1 gene of MHV-68 was only amplified in the positive control (lane P68) and not in 
MHV-72 (lane P72) and MHV-72-infected tissues (lane 1).  N, the negative control.
f:  Detection of MHV-DNA in MHV-72-infected mice  
P72  P68 N 1 2 3 4 5 6 7PCR for v-cyclin of MHV-68
PCR for M1 gene of MHV-68
739 bp –
P72    P68 N 1 
1 kbp – 
a b c
d e 200 nm
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no integration of HTLV-II genome (Hayashi et 
al., 1994).  Later a type of oncogenic virus, EBV-
related herpesvirus in Si-IIA cells (Si-IIA-EBV) 
was identified, and malignant lymphomas induced 
by Si-IIA in Japanese White rabbits as well as 
New Zealand White rabbits contained EBV-related 
DNA (Hayashi et al., 1995).  I also established a 
rabbit lymphoma model via the natural oropharyn-
geal route with Si-IIA-EBV (Koirala et al., 1997) 
as well as rabbit lymphoma induction via transfu-
sion with blood from Si-IIA-EBV-infected rabbits 
(Koirala et al., 2004).  In addition I confirmed the 
lymphomagenesis of rabbits by another EBV-like 
herpesvirus variant from cynomolgus (Cyno-EBV) 
(Hayashi et al., 1995; Chen et al., 1997).  However, 
intravenous inoculation of an HVMF1-infected cell 
line producing few virus particles (C54) made sero-
conversion in one of 10 rabbits and did not induce 
rabbit lymphomas.  Based on the sequence analysis 
of these three viruses, these can be considered vari-
ant virus each other (Hayashi et al., 1999, 2002; 
Hayashi and Akagi, 2000).  Therefore, I designate 
these three viruses of Si-IIA-EBV, Cyno-EBV and 
HVMF1 as Cynomolgus-EBV in this paper.
        Intravenous or peroral inoculation of Cyno-
EBV in rabbits induced a high rate of lymphoma-
genesis (77–90%).  All of the sera from rabbits in-
oculated intravenously or perorally with Cynomol-
gus-EBV-producing cells or EBV-producing B95-8 
cells showed increased anti-VCA IgG antibody 
titers (× 10–10,240).  The autopsy of tumor-bearing 
rabbits revealed marked splenomegaly, lymph node 
swelling and/or hepatomegaly with multiple white 
nodules.  White tumor nodules were less frequently 
found in the kidneys and heart.  Rarely, multiple 
peritoneal and skin metastatic tumors were ob-
served.
        A histological examination of rabbit tissues 
revealed malignant lymphomas involving many 
organs.  All of the involved tissues were classified 
as non-Hodgkin’s lymphoma, diffuse, large-cell or 
diffuse mixed type (Figs. 3a, b, e and f).  Bizarre 
giant cells were seen occasionally, admixed with 
lymphoma cells.  Less often, bizarre giant cells 
were identified in a non-neoplastic background, 
mimicking the morphology of Hodgkin’s lympho-
ma (Figs. 3c and d). 
        The in situ hybridization studies revealed that 
EBER-1 expression was detected in most Cynomol-
gus-EBV-producing cells and in about 90% cases 
of Cynomolgus-EBV-induced rabbit lymphoma. 
Most of the multinucleated bizarre giant cells 
among both neoplastic and non-neoplastic cells 
were positive (Figs. 3b and d). 
        Eleven T-cell lines harboring EBV-related 
DNA and EBER-1 expression were established 
from Cynomolgus-EBV-induced tumor-bearing 
rabbits (Fig. 3g).  Type I/II latency of EBV infec-
tion was observed in Cynomolgus-EBV-induced 
lymphomas and their cell lines.  Interestingly, six 
of them showed a deletion or translocation of 12q 
[12q–, 5 cases; t (7p+: 12q–), 1 case].  All cell lines 
except one (B6-J130LN) showed tumorigenicity in 
nude mice (Fig. 3h). 
        Direct sequencing of the three PCR products 
revealed that Si-IIA-EBV had about 82 % nucleo-
tide similarity to the human EBV DNA in three re-
gions (BRRF1 and IR1 regions) (Baer et al., 1984). 
Si-IIA-EBV had about 92.4% nucleotide similarity 
to HVMF1 (Ino et al., 1997).  Cyno-EBV DNA has 
77% base pair homology to EBV DNA from B95-8 
cells and 91% base pair homology to HVMF1 DNA 
in the IR1 region (Hayashi et al., 1999).  These se-
quence data indicate that Si-IIA-EBV has higher 
Table 3.  Comparison of genomic sequence of MHV variants and their pathogenesis in mice
Variants of Tumori- Spleno- t-RNA-like   Genes
     MHV genicity megaly sequences M1 through M3 M4   M5 through M12 
  MHV-68 + + + + + +
  MHV-72 + - - - + +
  MHV-76 - - - - - +
MHV, murine gammaherpesvirus. 
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Fig. 3.  Cynomolgus-EBV-induced lymphomas in rabbits.  Diffuse large cell lymphoma of the spleen (hematoxylin 
and eosin stain) (a) and EBER-1 (in situ hybridization) (b).  Hodgkin-like lymphomas with EBER-1 expression are 
rarely observed (hematoxylin and eosin stain) (c) and EBER-1 (in situ hybridization) (d).  Lymphoma cells also in-
filtrate into the testis (e) and brain (f).  Phase-contrast microphotograph of the rabbit lymphoma cell line (g) and its 
transplanted tumor in a nude mouse (h).
a b
c d
e f
g h
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sequence homology to HVMF1 and Cyno-EBV 
than human EBV from B95-8 suggesting that Cyno-
EBV, Si-IIA-EBV and HVMF1 differ from B95-
8-EBV and may be variants of each other (Hayashi 
and Akagi, 2000: Ohara et al., 2000).
        Rabbit lymphoma model induced by EBV-
like herpesvirus from Macaca arctoides:  Her-
pesvirus Macaca arctoides (HVMA) is an EBV-
like herpesvirus isolated from lymphoid cell line of 
the rhesus monkey species Macaca arctoides (Lapin 
et al., 1985).  Both simian T-cell leukemia virus 
(STLV-1) and HVMA are produced by MAL cell 
lines established from Macaca arctoides.  Inocu-
lation of MAL cells in rabbits induced malignant 
lymphomas and PCR analysis revealed the pres-
ence of T-cell leukemia virus-like sequence but not 
the presence of EBV-like sequence in rabbit lym-
phomas (Schatzl et al., 1993).  However, Wutzler et 
al. (1995) demonstrated the association of HVMA 
with the etiology of malignant lymphoma of rabbits 
inoculated with HVMA by detecting EBER-like 
transcripts expression and HVMA-DNA with PCR 
in the lymphoma cells.  Inoculation of HVMA into 
32 rabbits resulted in the seroconversion to EBV-
VCA and EBV-EA in all infected rabbits and show-
ing symptoms in 16 cases (50%) between 21 and 
143 days after inoculation, and the development of 
17 LPD (13 high-grade non-Hodgkin’s lymphomas 
and 4 lymphoid hyperplasia).  The phenotype of 
LPD was not described and latency type of EBV 
infection in rabbit LPD could not be determined. 
However, these findings suggested that HVMA 
caused a symptomatic infection and subsequent 
LPD development in rabbits (Wutzler et al., 1995).
        Rabbit T-cell lymphoma model induced by 
EBV-like-herpesvirus from Macaca nemestrina: 
Herpesvirus Macaca nemestrina (HVMNE) is 
a novel EBV-like virus isolated from a Macaca 
nemestrina with CD8+ T-cell mycosis fungoides-
cutaneous T-cell lymphoma (Rivadeneira et al., 
1999).  A new rabbit T-cell lymphoma model by 
HVMNE has been reported (Ferrari et al., 2001). 
Intravenous inoculation of HVMNE-infected 
T-cells or cell-free HVMNE in New Zealand 
White rabbits resulted in seroconversion to EBV-
VCA in 7 of 10 rabbits and 1 of 4 rabbits, respec-
tively.  And all 8 seroconverted rabbits developd 
T-cell lymphoma within 3 to 9 months after inocu-
lation.  Necropsy revealed splenomegaly or hepa-
tomegaly or both in most tumor-bearing animals. 
White nodules were frequently found in kidneys, 
heart and lungs.  Lymph node enlargement and skin 
involvement were rarely observed.  Histologically, 
diffuse mixed lymphoma cells infiltrated involv-
ing many organs of rabbits.  Viral sequences from 
tissue DNA were detected by PCR in all lympho-
matous rabbits.  Not all cells within the lymphoid 
infiltrates expressed EBER-specific viral RNA, 
and the intensity of the EBV EBER staining varied 
among cells of the same tissue.  Possibly the low-
level expression found using EBER was related to 
a suboptimal sensitivity of this technical approach 
owing to the incomplete homology of the probe 
used because the DNA sequence encoding EBER 
from HVMNE is unknown.  HVMNE-DNA and 
EBV-like RNA expression was also detected in two 
transformed T-cell lines established from two lym-
phomatous rabbits.  Analysis of one of these T-cell 
lines demonstrated the persistence of HVMNE-
DNA, expression of an LMP1-like protein, acquisi-
tion of interleukin-2 independence, and constitutive 
activation of the Jak/STAT pathway.  HVMNE in-
fection of rabbits provides a valuable animal model 
for human EBV-associated T-cell lymphoma where-
by genetic determinants for T-cell transformation 
by this EBV-like animal virus can be studied.
        Baboon EBV (herpesvirus papio)-induced 
rabbit model for EBV-associated fatal LPD with 
virus-associated hemophagocytic syndrome 
(VAHS):  Human EBV-associated hemophagocytic 
syndrome (EBV-AHS), has a poor prognosis and is 
often noted in patients with fatal IM (Mroczek et 
al., 1987; Okano and Gross, 1996), fatal childhood 
with T-cell LPD (Su et al., 1994, 1995; Kikuta, 
1995), chronic active EBV infection (Yamashita 
et al., 1998), and malignant lymphomas (MLs), 
particularly EBV-infected T-cell lymphoma (Craig 
et al., 1992; Su et al., 1993).  Patients with HPS 
exhibit common clinicopathologic features such as 
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fever, skin lesions, lung infiltrates, hepatospleno-
megaly with jaundice and liver dysfunction, pancy-
topenia and coagulopathy.  The liver, spleen, lymph 
nodes and bone marrow are usually infiltrated with 
proliferated florid histiocytes with hemophagocy-
tosis as well as proliferated atypical lymphocytes. 
Increased serum levels of many cytokines includ-
ing soluble IL-2, IL-1, IL-3 and IL-6, macrophage 
colony stimulating factor, interferon-γ, prostaglan-
dins and tumor necrosis factor-alpha (TNF-α) 
have also been reported (Su et al., 1995; Okano and 
Gross, 1996).
        Herpesvirus papio (HVP) infection-related 
rabbit fatal LPD with VAHS, which is described in 
detail as in the following, is the first animal model 
for human EBV-fatal LPD with VAHS (Hayashi et 
al., 2001, 2003a).
        An HVP-producing baboon lymphoblastoid 
cell line (594S) or cell-free HVP virion pellets 
obtained from 594S culture were intravenously in-
oculated into female New Zealand White rabbits. 
Of the 13 rabbits inoculated intravenously with 
HVP-producing simian 594S cells, 11 (85%) died 
of LPD 22 to 105 days after inoculation.  LPD was 
also accompanied by VAHS in 9 of these 11 rab-
bits.  Peroral inoculation of cell-free HVP resulted 
in viral infection in 3 of 5 rabbits, with 2 of the 3 
infected rabbits dying of LPD with VAHS (51–81 
days).  LPD with VAHS was also induced in 7 of 
7 rabbits (100%) by intravenous injection of cell-
free HVP 21 to 28 days after inoculation.  In total, 
only 3 infected rabbits remained free of LPD.  Two 
of the rabbits that showed no seroconversion after 
peroral inoculation exhibited no abnormalities. 
        Increased anti-EBV-VCA IgG antibody titers 
(× 40–2,560) were detected in all sera from rabbits 
inoculated intravenously with 594S (HVP).  How-
ever, increased anti-VCA-IgG antibodies levels 
were found in only 3 of the 5 rabbits inoculated 
perorally with cell-free virion pellets.  Peripheral 
blood (PB) examination of some rabbits with LPD 
and VAHS revealed elevated GOT (≤ 116 IU/L), 
GPT (≤ 109 IU/L) and LDH (≤ 1,557 IU/L), and 
leukocytosis (≤ 21,500/mm3) with mildly increased 
levels of atypical lymphocytes (1–10 %).  Tran-
sient mild leukopenia (3,700–5,400/mm3) was also 
found in 4 of the 10 rabbits examined.
        Except for anorexia and emaciation, most 
rabbits inoculated with HVP appeared physi-
cally normal, but showed severe bloody rhinorrhea 
(Fig. 4a) and dyspnea during the few days before 
death.  Autopsy of the infected rabbits frequently 
revealed pulmonary congestion and edema, often 
accompanied with severe hemorrhage of the lungs. 
Mild or marked splenomegaly with congestion and 
hemorrhage (Fig. 4b) was often observed, as well 
as dark purple, swollen lymph nodes with hemor-
rhage (Fig. 4c) and/or hepatomegaly.  White nod-
ules were sometimes found in spleen, liver or heart 
cross-sections.  Histological examination of rabbit 
tissues revealed mild to severe infiltration of atypi-
cal pleomorphic lymphoid cells involving many 
organs.  Atypical large or medium-sized lymphoid 
cells without Hodgkin’s cell-like morphology in-
filtrated around perivascular areas with a diffuse 
or nodular pattern.  Apoptotic cells (individual cell 
necrosis) accompanied by histiocytes containing 
cellular debris were often observed in the atypical 
cell-infiltrated lesions. Lymph nodes, spleen, and 
liver were frequently and markedly involved. Most 
involved lymph nodes showed diffuse infiltrations 
of atypical lymphoid cells and marked hemophago-
cytosis in the sinus (Figs. 4d and e).  Involved livers 
showed severe periportal and sinusoidal infiltration 
of atypical lymphoid cells (Figs. 4f and g), which 
was often accompanied by central necrosis of the 
hepatic lobules.  Atypical lymphocytes were often 
found in the blood vessels.  Hemophagocytosis was 
also found in the spleen, bone marrow and thymus. 
        Six rabbit T-cell lines with IL-2 dependency 
were established from 3 of the 5 HVP-infected 
Japanese White rabbits.  Five of 6 cell lines had the 
normal rabbit female karyotype (44, XX), while 
one had an abnormal karyotype (Hayashi et al., 
2003a).  In 18 of 20 LPD cases (90%), EBER-1 
expression was detected in virtually all atypical 
lymphoid cells (Figs. 4e and g).  EBER-1-positive 
atypical lymphoid cells infiltrated not only the 
parenchyma and stroma of the various organs, but 
were also sometimes demonstrated in the vessels, 
lymph nodal sinus or hepatic sinusoid.  The six rab-
bit lymphoid cell lines also expressed EBER-1.
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Fig. 4.  Baboon-EBV (HVP)-induced lymphoproliferative diseases with hemophagocytosis in rabbits.  Rabbit nasal 
bleeding due to bleeding tendency (a).  Splenomegaly (b) and lymph node swelling with hemorrhage (c).  Atypical 
lymphocyte infiltration and marked hemophagocytosis in lymph nodes (hematoxylin and eosin stain) (d) and HVP-
EBER-1 (in situ hybridization) (e).  Atypical lymphocyte infiltration in the liver (hematoxylin and eosin stain) (f) 
and HVP-EBER-1 (in situ hybridization) (g).  (h) Detection of HVP-EBNA1 DNA by PCR.  HVP-EBNA1 DNA was 
amplified in the positive control (lane P) and HVP-infected rabbit tissues (lanes 1 through 7) but not in the negative 
controls (lane N).      
h: 389 bp –
P   1 2 3 4 5 6 7 N N
PCR for HVP-EBNA1
a
b
c
d e
f g
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        PCR for the HVP-EBNA-1 region was car-
ried out using the primer pair HPNA-1S:  5'-CTG 
GGT TGT TGC GTT CCA TG-3' and HPNA-1A: 
5'-TTG GGG GCG TCT CCT AAC AA-3'.  Ampli-
fied DNA of the expected size of 389 bp was dem-
onstrated in the positive control (594S) and 594S 
(HVP)-induced rabbit LPD lesions (Fig. 4h) as 
well as in peripheral blood from the infected rab-
bits.  PCR analysis revealed the presence of HVP-
DNA in all six rabbit cell lines established from 
HVP-infected rabbits.  Clonality analysis using the 
HVPTR2 probe revealed monoclonal or oligoclonal 
bands in 594S (HVP)-induced rabbit LPD lesions 
(data not shown).
        On the latency of EBV infection, while 
cross-reactive EBNA-2 expression by immuno-
fluorescence test was detected in 594S cells, neither 
EBNA-1 nor LMP-1 cross-reactivity was observed. 
HVP-EBNA1 and HVP-EBNA2 mRNAs were de-
tected by reverse transription-PCR in 594S cells 
and HVP-induced rabbit LPD lesions, suggesting 
the latency type III.  HVP-LMP1 transcripts were 
detected in 2 of the 4 in vivo samples. However, 
reverse transription-PCR revealed mRNA expres-
sion of both HVP-EBNA1 and HVP-LMP1 but 
not of HVP-EBNA2 in rabbit T cell lines (data not 
shown), suggesting the latency type II.
        I consider that this rabbit model of fatal LPD 
with VAHS induced by primary infection of HPV 
is a useful animal model for fatal childhood EBV-
AHS (Kikuta et al., 1993; Su et al., 1994, 1995; 
Chen et al., 1997).  Those results mentioned above 
suggested that the clinicopathologic features of the 
rabbit model were similar to those of fatal child-
hood EBV-AHS described by Su et al. (1994, 
1995).
        To determine the nature of HVP-induced rab-
bit LPD, it is important to determine if the atypi-
cal lymphocytes in rabbit LPDS were reactive or 
neoplastic, that is, whether or not they exhibited 
clonal cytogenetic abnormalities.  Both oligoclonal 
and monoclonal expansion of HVP-infected rabbit 
lymphoid cells in rabbit LPD in vivo was observed 
by Southern blot analysis of EBV termini.  How-
ever, chromosomal analysis revealed normal rabbit 
karyotypes in cells from all 10 in vivo LPD lesions 
from 5 rabbits examined, and in 5 of the 6 IL-2 
dependent rabbit cell lines (Hayashi et al., 2003a). 
This suggested that most in vivo rabbit LPD cells 
were non-neoplastic in nature.  In addition, the rab-
bits with HVP infection usually died within a short 
time of VAHS.  Based on these results, it is pos-
sible that most HVP-infected rabbits die relatively 
quickly of severe LPD and VAHS with bleeding 
in the presence of oligoclonal LPD, before the de-
velopment of completely monoclonal neoplastic 
lymphoma.  However, it is also possible that these 
rabbit LPD lesions may contain some small com-
ponents of neoplastic or pre-neoplastic cells with 
HVP infection.
        Therapeutic trials with vidarabine or CHOP* 
for a rabbit model of EBV-AHS were not succeed-
ed (Hayashi et al., 2003b).
Comparative analysis of the rabbit models 
with human EBV-associated LPD
Four rabbit models using simian EBV-like viruses 
have been reported (Table 2).  Three of them us-
ing Cynomolgus-EBV, HVMA and HVMNE are 
animal models for human EBV-associated malig-
nant lymphoma.  Cynomolgus-EBV- or HVMNE-
induced rabbit malignant lymphoma showed T-cell 
phenotype, while phenotype of HVMA-induced 
rabbit malignant lymphoma was not determined.  It 
is very interesting that Cynomolgus-EBV (Si-IIA-
EBV and HVMF1) and HVMA were isolated from 
the simian cell lines infected with retroviruses such 
as HTLV-II, SIV or STLV, respectively.  Among 
these three viruses, Cynomolgus-EBV can induce 
rabbit lymphoma the most frequently (90%) and 
is the only one kind to be demonstrated to trans-
mit to rabbits by natural peroral infection and to 
result in rabbit lymphoma development.  The la-
tency type I/II of Cynomolgus-EBV induced rabbit 
T-cell lymphoma is compatible with that of human 
EBV-associated T-cell lymphoma.  However, sim-
* CHOP, combination chemotherapy consisting of cyclophosphamide, hydroxydaunomycin, oncovin and 
prednisone.
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ian EBV-like viruses (Cyno-EBV, HVMA and 
HVMNE) infection of rabbits resulted in T-cell 
lymphomas several months of latent period after 
primary infection, while the latency period be-
tween the primary EBV infection and human EBV-
associated T-cell lymphoma development is consid-
ered more than 30 years.  The direct causative rela-
tion between primary simian EBV-like viruses and 
subsequent rabbit T-cell lymphomas is very clear. 
However, additional events such as some genetic 
alterations must be needed to develop human EBV-
associated T-cell lymphomas during long latent 
infection of EBV after the primary EBV infection. 
If possible, I need to develop some animal models 
with long latent virus infection and subsequent 
T-cell lymphomas for human EBV-associated 
T-cell lymphomas. 
        As the clinicopathologic features of HVP-
infected rabbit model are very similar to those of 
fatal childhood EBV-AHS with T-cell LPD (Su 
et al., 1994) or fulminant EBV-positive T-cell 
LPD following acute /chronic EBV infection 
(Quintanilla-Martinez et al., 2000), I suggest that 
this rabbit model of fatal LPD with VAHS, induced 
by a primary natural route of HPV infection, repre-
sents an animal model for fulminant EBV-positive 
T-cell LPD with VAHS due to primary EBV infec-
tion. This system may be useful for the study of 
human EBV-AHS pathogenesis, prevention and 
treatment. 
Perspectives on animal models of EBV-
associated diseases
In spite of the many investigations into the role 
of EBV infection in the pathogenesis of EBV-
associated diseases, a direct causal relationship 
between EBV infection and these tumors has been 
established only in primary EBV infection related 
diseases including infectious mononucleosis and 
EBV-AHS in childhood and the opportunistic 
LPDs arising with a relatively short latency period 
in immunocompromized hosts.  However, most 
EBV-associated tumors arise with a very long la-
tency in long-term EBV carriers.  This suggests the 
multistep oncogenesis by risk factors and malignant 
transformation from a single cell within the EBV-
infected pool (Rickinson and Kieff, 2001).  It is 
generally accepted that risk factors such as genetic 
background, ethnicity, environmental factors in-
cluding nitrosamines in foods, economic status and 
malarial or helicobacter pylori infection and the 
mutation or deletion of genes like p53 are needed 
for the development of the other EBV-associated 
tumors.  EBV contributes to the malignant phe-
notype, such as growth in low serum concentra-
tion, anchorage-independent growth in soft agar, 
and tumorigenicity in nude mice (Shimizu et al., 
1994), and oncogenic role of EBERs and resistance 
to apoptosis by EBERs are also demonstrated in 
Burkitt’s lymphoma cell line Akata (Komano et al., 
1999; Ruf et al., 2000).  Insulin-like growth factor 
1 induced by EBERs acts as an autocrine growth 
factor for EBV-positive gastric carcinoma (Iwakiri 
et al., 2003).  On the other hand, there are different 
hypotheses that EBV is only an innocent bystander 
virus or that EBV just infects the tumor cells after 
the malignant transformation of EBV-non-infected 
cells and EBV does not contribute to the oncogenic 
process (Ohshima et al., 1998).
        The direct causative relationship between 
infection by EBV-related virus and the subse-
quent development of malignant lymphoma is very 
clear in this rabbit experimental model by EBV-
related virus, reinforcing the assertion that EBV 
has the significant role in the development of EBV-
associated tumors.  According to the comparative 
overview data of EBV-associated lymphomas in 
human and rabbits (Tables 1 and 2), these rabbit 
LPDs induced by EBV-like viruses are very good 
models for the fatal lymphoproliferative disease 
seen in fatal infectious mononucleosis/fatal LPD 
with a virus-associated hemophagocytic syndrome 
and EBV-positive T cell lymphoma.  In addition, 
new animal models developing after long latent 
infection are needed for human T-cell lymphoma 
with a very long latency in long-term EBV carriers. 
In view of the scarcity and expense of non-human 
primates, these rabbit models are very useful and 
inexpensive alternative experimental models for 
studying the biology and pathogenesis of EBV, 
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especially in relation to human EBV-related lym-
phomas.  Rabbit models with Cynomolgus-EBV or 
HVP can also be used for studying the mechanism 
of the natural oropharyngeal route of infection by 
EBV-related virus.
        On the present animal models in vivo of EBV 
infection and EBV-associated diseases, all animal 
models are useful for studying EBV-associated 
LPD or EBV-related lymphomas, and most of them 
are acute or subacute models with short latency and 
develop by primary virus infection.  Mouse models 
using murine gamma-herpesvirus is the only one 
for EBV-related lymphoma with a very long latency 
in long-term gamma-herpesvirus carriers.  Rhesus 
monkey model using LCV-naïve rhesus monkeys 
infected with rhesus LCV is a very excellent one 
for natural primary EBV infection and subsequent 
latent EBV infection, because essentially the same 
virus-host interactions have been maintained in 
this system.  However, rhesus LCV-related tumors 
without immunodeficiency have not been detected 
yet.  These animal models in vivo also provide a 
means of studying prophylactic regimens such as 
recombinant vaccines and CTL epitope peptide-
based vaccines.  These are useful in vivo system 
to test novel therapies including new drugs, CTL-
based immune therapy and gene therapy directed 
against the EBV-positive LPD or lymphomas which 
are usually refractory to conventional chemo-
therapy (Franken et al., 1996; Barnes et al., 1999). 
However, it is noteworthy that there have been no 
animal models in vivo for EBV-infected epithelial 
tumors such as a set of nasopharyngeal carcinoma 
or gastric carcinoma, because the cases of EBV-
associated gastric carcinoma (6.7% or 4.7–11.2% 
of gastric carcinoma cases) (Tokunaga et al., 1993; 
Koriyama et al., 2001, respectively) is the largest in 
number among EBV-related tumors in Japan.  To 
elucidate the detail pathogenesis of EBV-associated 
diseases using animal models, sequential follow-up 
studies and clarifying functions of the oncogenes 
of EBV or EBV-like viruses are needed.  Animal 
models infected with defected EBV-like virus de-
leting some important oncogenes will be also useful 
for the function of the oncogenes.  Why rabbits are 
so highly susceptible to lymphomagenesis induced 
by simian EBV-like viruses is not clear. I could not 
demonstrate the lymphomagenesis in some strains 
of mice, rats and hamsters (unpublished data).  The 
mechanism of cross-species virus transmission 
should be elucidated. 
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